As an important clinical treatment and scientific research tool, induced pluripotent stem cells (iPSC) have shown huge application potential.

The results of this study demonstrate the feasibility and adequacy of inducing skin cells derived from patients with late-onset Alzheimer's disease to transform into neurons in a 3D environment.

As the core technology of the third medical revolution, stem cell technology is promoting profound changes in the medical field.

The conclusions of on-site inspections of clinical trials in the United States are divided into: OAI: "Serious problems require official administrative measures".

At 10:00 a.m. on August 16, 2024, the 2024 Future Science Awards announced this year's "Life Science Award" to Professor Deng Hongkui, a stem cell biologist at Peking University.

iPSC has significant advantages in treating CNS diseases.

Stem cell research is developing rapidly, offering exciting possibilities for treating a variety of diseases and injuries. Two outstanding figures in this field are: mesenchymal stem cells (MSC) and induced pluripotent stem cells (iPSC).

Stem cells have become a promising candidate for treating more than 200 diseases and are conducting more than 6000 clinical trials around the world.